ANI Pharmaceuticals
ANIP
$64.20
Share price
-3.46%
Change (1 day)
1.05%
Change (1 year)
Categories
ANI Pharmaceuticals (ANIP) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : $0.84 Billion USD
According to ANI Pharmaceuticals's latest financial reports the company's total liabilities are $0.84 Billion USD. A company’s total liabilities is the sum of all current and non-current debts and obligations.
ANI Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | $0.85 B | 91.39% |
| 2023-12-31 | $0.44 B | 6% |
| 2022-12-31 | $0.42 B | 2.1% |
| 2021-12-31 | $0.41 B | 55.51% |
| 2020-12-31 | $0.26 B | 8.81% |
| 2019-12-31 | $0.24 B | 4.57% |
| 2018-12-31 | $0.23 B | -1.7% |
| 2017-12-31 | $0.23 B | 54.93% |
| 2016-12-31 | $0.15 B | 22.39% |
| 2015-12-31 | $0.12 B | 4.52% |
| 2014-12-31 | $0.11 B | 3285.33% |
| 2013-12-31 | $3.53 M | -66.6% |
| 2012-12-31 | $10.59 M | -56.87% |
| 2011-12-31 | $24.56 M | -4.12% |
| 2010-12-31 | $25.61 M | 24.33% |
| 2009-12-31 | $20.6 M | 434.82% |
| 2008-12-31 | $3.85 M | 154.18% |
| 2007-12-31 | $1.51 M | -64.74% |
| 2006-12-31 | $4.29 M | 56.03% |
| 2005-12-31 | $2.75 M | 44.52% |
| 2004-12-31 | $1.9 M | 116.38% |
| 2003-12-31 | $0.88 M | -29.85% |
| 2002-12-31 | $1.25 M | 35.4% |
| 2001-12-31 | $0.92 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Jazz Pharmaceuticals JAZZ | $7.35 B | 766.92% | 🇮🇪 Ireland |
 Evoke Pharma
EVOK | $10.53 M | -98.76% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $32.14 B | 3,686.52% | 🇮🇱 Israel |
 Pfizer PFE | $117.39 B | 13,727.66% | 🇺🇸 USA |
 Lannett Company LCI | $0.74 B | -12.02% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | $36.49 M | -95.70% | 🇺🇸 USA |
 Cardinal Health CAH | $51.76 B | 5,997.95% | 🇺🇸 USA |
 Novartis NVS | $61.48 B | 7,142.88% | 🇨🇭 Switzerland |
 Royalty Pharma RPRX | $7.81 B | 821.08% | 🇬🇧 UK |